| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvectis Pharma, Inc. (NVCT) has 7 insiders with recent SEC Form 4 filings, including 19 buys and 0 sells. NVCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.68M | $71.94M | - | |
| 10% | 3.14M | $61.38M | - | |
| Other | 1.81M | $35.35M | - | |
| Other | 1.79M | $35.09M | - | |
| VP | 200.1K | $3.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | Poradosu Enrique70 | Chief Science &Business Off | Buy | 670 | $15.33 | $10,273.20 | - | -53.2% | -10.5% | |
| May 12, 2022 | Shemesh Shay72 | Chief Dev. &Ops. Officer | Buy | 1,278 | $15.85 | $20,254.66 | - | -53.2% | -10.5% | |
| May 12, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 12,245 | $16.99 | $208,046.70 | +0.1% | -53.2% | -10.5% | |
| May 12, 2022 | Kaplan Matthew L. | Director | Buy | 3,000 | $16.88 | $50,632.73 | +4.5% | -53.2% | -10.5% | |
| May 12, 2022 | Hoberman Kenneth | Director | Buy | 6,000 | $17.40 | $104,400.00 | +12.2% | -53.2% | -10.5% | |
| Mar 28, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 4,000 | $7.05 | $28,200.00 | +0.1% | +76.4% | +75.2% | |
| Mar 17, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 7,000 | $7.63 | $53,410.00 | +0.2% | +33.2% | +56.6% | |
| Feb 14, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 8,000 | $5.88 | $47,040.00 | +0.3% | +251.2% | +97.8% | |
| Feb 10, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 8,500 | $6.34 | $53,890.00 | +0.3% | +157.6% | +133.3% | |
| Feb 7, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 232,500 | $4.96 | $1,153,145.00 | +2.1% | +89.4% | +37.0% |